Literature DB >> 21529780

Induction of prolonged mania during ketamine therapy for reflex sympathetic dystrophy.

Amy K Ricke, Riley J Snook, Amit Anand.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21529780      PMCID： PMC3465663          DOI： 10.1016/j.biopsych.2011.02.030

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  8 in total

1.  N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants.

Authors:  John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2010-11

2.  Pharmacodynamic profiles of ketamine (R)- and (S)- with 5-day inpatient infusion for the treatment of complex regional pain syndrome.

Authors:  Michael E Goldberg; Marc C Torjman; Robert J Schwartzman; Donald E Mager; Irving W Wainer
Journal:  Pain Physician       Date:  2010 Jul-Aug       Impact factor: 4.965

3.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Authors:  Nancy Diazgranados; Lobna Ibrahim; Nancy E Brutsche; Andrew Newberg; Phillip Kronstein; Sami Khalife; William A Kammerer; Zenaide Quezado; David A Luckenbaugh; Giacomo Salvadore; Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Arch Gen Psychiatry       Date:  2010-08

4.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

5.  Antidepressant effects of ketamine in depressed patients.

Authors:  R M Berman; A Cappiello; A Anand; D A Oren; G R Heninger; D S Charney; J H Krystal
Journal:  Biol Psychiatry       Date:  2000-02-15       Impact factor: 13.382

6.  Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

Authors:  A Anand; D S Charney; D A Oren; R M Berman; X S Hu; A Cappiello; J H Krystal
Journal:  Arch Gen Psychiatry       Date:  2000-03

7.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

Authors:  J H Krystal; L P Karper; J P Seibyl; G K Freeman; R Delaney; J D Bremner; G R Heninger; M B Bowers; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1994-03

8.  Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Authors:  Marije aan het Rot; Katherine A Collins; James W Murrough; Andrew M Perez; David L Reich; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382
  8 in total
  7 in total

Review 1.  Complex Regional Pain Syndrome, Current Concepts and Treatment Options.

Authors:  Ivan Urits; Abra H Shen; Mark R Jones; Omar Viswanath; Alan D Kaye
Journal:  Curr Pain Headache Rep       Date:  2018-02-05

2.  Synaptotagmin-7 deficiency induces mania-like behavioral abnormalities through attenuating GluN2B activity.

Authors:  Qiu-Wen Wang; Si-Yao Lu; Yao-Nan Liu; Yun Chen; Hui Wei; Wei Shen; Yan-Fen Chen; Chong-Lei Fu; Ying-Han Wang; Anbang Dai; Xuan Huang; Fred H Gage; Qi Xu; Jun Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

Review 3.  Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.

Authors:  John H Krystal; Gerard Sanacora; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382

4.  Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.

Authors:  Mark J Niciu; David A Luckenbaugh; Dawn F Ionescu; Daniel C Mathews; Erica M Richards; Carlos A Zarate
Journal:  Biol Psychiatry       Date:  2013-05-28       Impact factor: 13.382

Review 5.  Modeling mania in preclinical settings: A comprehensive review.

Authors:  Ajaykumar N Sharma; Gabriel R Fries; Juan F Galvez; Samira S Valvassori; Jair C Soares; André F Carvalho; Joao Quevedo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-04       Impact factor: 5.067

6.  Mania following ketamine abuse.

Authors:  Yuan-Yuan Lu; Chieh-Hsin Lin; Hsien-Yuan Lane
Journal:  Neuropsychiatr Dis Treat       Date:  2016-01-27       Impact factor: 2.570

7.  Ketamine-induced affective switch in a patient with treatment-resistant depression.

Authors:  Girish Banwari; Prutha Desai; Prahlad Patidar
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.